Evidence map›Paper›PMID 27649880›Full record

ReviewNature reviews. Molecular cell biology2016

Roles of eukaryotic topoisomerases in transcription, replication and genomic stability.

Yves Pommier, Yilun Sun, Shar-Yin N Huang, John L Nitiss

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 573 papers.

0numbers the graph read from it
0cells of the map it votes in
573citing papers in PubMed
44.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

573 citing papers in PubMed, 937 citations in OpenAlex.

  1. Gut microbes · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. A multispecies toolkit ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Topology Resetting During Transcription-Coupled Nucleotide Excision Repair.International journal of molecular sciences · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

513 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yves PommierDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Yilun SunCollege of Pharmacy, University of Illinois, Rockford, Illinois 61107, USA.
Shar-Yin N HuangDevelopmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
John L NitissCollege of Pharmacy, University of Illinois, Rockford, Illinois 61107, USA.
University of Illinois Chicago, Rockford campus · USCenter for Cancer Research · USNational Cancer Institute · US

Funding

ANTITOPOISOMERASE DRUG ACTION IN YEASTR01CA052814 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NITISS, JOHN L · 1990 to 2014
$2.7M
DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGSZ01BC006161 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI POMMIER, YVES · 1996 to 2008
$1.5M
Regulation of non-homologous end joining through end processingR21CA187651 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HANAKAHI, LESLYN A · 2014 to 2015
$361k
Intramural NIH HHS Z01 BC006161NCI NIH HHS R01 CA052814NCI NIH HHS R21 CA187651
6 · The paper itself

Abstract

Topoisomerases introduce transient DNA breaks to relax supercoiled DNA, remove catenanes and enable chromosome segregation. Human cells encode six topoisomerases (TOP1, TOP1mt, TOP2α, TOP2β, TOP3α and TOP3β), which act on a broad range of DNA and RNA substrates at the nuclear and mitochondrial genomes. Their catalytic intermediates, the topoisomerase cleavage complexes (TOPcc), are therapeutic targets of various anticancer drugs. TOPcc can also form on damaged DNA during replication and transcription, and engage specific repair pathways, such as those mediated by tyrosyl-DNA phosphodiesterase 1 (TDP1) and TDP2 and by endonucleases (MRE11, XPF-ERCC1 and MUS81). Here, we review the roles of topoisomerases in mediating chromatin dynamics, transcription, replication, DNA damage repair and genomic stability, and discuss how deregulation of topoisomerases can cause neurodegenerative diseases, immune disorders and cancer.

Indexed as

DNA ReplicationGenomic InstabilityTranscription, GeneticAnimalsDNA DamageDNA RepairDNA TopoisomerasesHumansMitochondriaDNA Topoisomerases

Identifiers

PMID27649880
PMCPMC9248348
OpenAlexW2523410070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.